HKU Scholars Hub: Browsing DSpace

Browsing by Author Law, CT

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 20

Title	Author(s)	Issue Date
Aberrant super-enhancer landscape in human hepatocellular carcinoma Journal:Hepatology	Tsang, FH Law, CT Tang, TCC Cheng, CL Chin, DW Tam, WSV Wei, L Wong, CCL Ng, IOL Wong, CM	2019
Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species Journal:Hepatology	Lee, D Zhang, MS Tsang, FHC Bao, MHR Xu, IMJ Lai, RKH Chiu, DKC Tse, APW Law, CT Chan, CYK Yuen, VWH Chui, NNQ Ng, IOL Wong, CM Wong, CCL	2021
Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer Journal:Communications Biology	Cheng, CLH Tsang, FHC Wei, L Chen, M Chin, DWC Shen, J Law, CT Lee, D Wong, CCL Ng, IOL Wong, CM	2021
Chromatin remodeler HELLS is an epigenetic driver for hepatocellular carcinoma progression Proceeding/Conference:Cancer Research	Law, CT Wei, LL Tsang, FH Chan, CY Xu, MJI Lai, RK Ho, DWH Lee, JKM Wong, CCL Ng, IOL Wong, CM	2017
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma Journal:Journal of Clinical Investigation	LEE, D XU, M CHIU, KC LAI, KH Tse, PW Li, LL LAW, CT Tsang, FH Wei, L CHAN, YK Wong, CM Ng, IOL Wong, CCL	2017
Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer Journal:Cell Reports	Bao, MHR Yang, C Tse, APW Wei, L Lee, D Zhang, MS Goh, CC Chiu, DKC Yuen, WH Law, CT Chin, WC Chui, NNQ Wong, BPY Chan, CYK Ng, IOL Chung, CYS Wong, CM Wong, CCL	2021
HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma Journal:Hepatology	LAW, CT Wei, L Tsang, FHC CHAN, CYK XU, IMJ LAI, RKH Ho, DWH Lee, JMF Wong, CCL Ng, IOL Wong, CM	2019
Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers Journal:Cell Reports	Shen, J Yang, C Zhang, S Chin, WC Chan, FF Law, CT WANG, G CHENG, LHC CHEN, M WAN, TCR WU, M KUANG, Z Sharma, R Lee, KW Ng, IOL Wong, CCL Wong, CM	2022
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3 Journal:Journal of Hepatology	Wei, L Chiu, KC Tsang, FH Law, CT Cheng, LHC Au, LKS Lee, MF Wong, CCL Ng, IOL Wong, CM	2017
Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway Journal:Cell Death & Disease	Chiu, DKC Tse, PW LAW, CT XU, JMJ LEE, D CHEN, M LAI, RKH YUEN, VWH CHEU, JWS Ho, DWH Wong, CM Zhang, H Ng, IOL Wong, CCL	2019
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development Journal:Science Advances	Cheu, JWS Chiu, DKC Kwan, KKL Yang, CX Yuen, VWH Goh, CC Chui, NNQ Shen, W Law, CT Li, QD Zhang, MS Bao, MHR Wong, BPY Chan, CYK Liu, CX Sit, GFW Ooi, ZY Deng, HJ Tse, APW Ng, IOL Wong, CCL	5-May-2023
In vivo genome-wide CRISPR activation screening identifies functionally important long non-coding RNAs in hepatocellular carcinoma. Journal:Cell Mol Gastroenterol Hepatol	WONG, LS Wei, L WANG, G LAW, CT Tsang, FH Chin, WC Ng, IOL Wong, CM	2022
MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis Journal:Oncotarget	Wong, CM Wei, L Au, SLK Fan, DNY Zhou, Y Tsang, FHC Law, CT Lee, JMF He, X Shi, J Wong, CCL Ng, IOL	2015
NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma Journal:Clinical Cancer Research	Lai, KH Xu, M Chiu, KC Tse, PW Wei, L Law, CT Lee, D Wong, CM Wong, MP Ng, IOL Wong, CCL	2016
PLK4 inhibitor suppresses hepatocellular carcinoma (HCC) through inducing extensive polyploidy and activating STING pathway Proceeding/Conference:EMBO Workshop: Cell death in immunity and inflammation	Chan, CY Chiu, KC Yuen, WH Law, CT Lee, D Tse, PW Tan, K Zhang, S Khong, PL Yau, T Ng, IOL Bray, MR Mak, TW Wong, CCL	2019
Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity Journal:Hepatology	Chan, YK YUEN, WH Chiu, KC Goh, CC Thu, KL Cescon, DW Soria‐Bretones, I Law, CT CHEU, WS Lee, D Tse, PW Tan, KV Zhang, S WONG, PY Wong, CM Khong, PL Ng, IOL Bray, MR Mak, TW Yau, TCC Wong, CCL	2022
Pushing ploidy to activates STING cytosolic sensing pathway as a novel therapeutic approach in hepatocellular carcinoma (HCC). Proceeding/Conference:Hong Kong Inter-University Postgraduate Symposium in Biochemical Sciences 2019	Chan, CY Chiu, KC Yuen, WH Lee, D Law, CT Tse, PW Tan, K Zhang, S Khong, PL Yau, T Wong, CM Bray, M Ng, IOL Mak, TW Wong, CCL	2019
Pushing ploidy to its limit as a novel therapeutic approach in hepatocellular carcinoma (HCC) Proceeding/Conference:Hong Kong Society of Flow Cytometry 24th Annual General Meeting and Scientific Meeting	Chan, CY Chiu, KC Yuen, WH Lee, D Law, CT Tse, PW Tang, K Zhang, S Khong, PL Yau, T Bray, M Ng, IOL Mak, TW Wong, CCL	2019
Transketolase counteracts oxidative stress to drive cancer development Journal:Proceedings of the National Academy of Sciences	Xu, M Lai, KH Lin, SH Tse, PW Chiu, KC Koh, HY Law, CT Wong, CM Cai, Z Wong, CCL Ng, IOL	2016
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses Journal:International Journal of Hepatology	Yuen, VWH Chiu, DKC Law, CT Cheu, JWS Chan, CYK Wong, BPY Goh, CC Zhang, MS Xue, HDG Tse, APW Zhang, Y Lau, HYH Lee, DR Au-Yeung, RKH Wong, CM Wong, CCL	29-Nov-2022

Showing results 1 to 20 of 20